Federal regulators Wednesday night gave Genzyme Corp. the go-ahead to sell a new pill to treat multiple sclerosis in the United States. The positive ruling for the Cambridge biotechnology company’s therapy, called Aubagio, marks the Food and Drug Administration’s first approval of a Genzyme drug since French pharmaceutical giant Sanofi SA bought Genzyme for $20.1 billion in 2010.
Aubagio Summary
http://msworld.org/forum/showthread....09#post1369109
Prescribing Information (PDF format)
http://products.sanofi.us/aubagio/aubagio.pdf
News Article
http://online.wsj.com/article/SB1000...388247012.html
Aubagio Summary
http://msworld.org/forum/showthread....09#post1369109
Prescribing Information (PDF format)
http://products.sanofi.us/aubagio/aubagio.pdf
News Article
http://online.wsj.com/article/SB1000...388247012.html
Comment